Haemophilus Infections

Approved for this indication (6)

• DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
• menitorix
• Haemophilus influenzae Type b Conjugate and Hepatitis B (Recombinant)
• haemophilus influenzae type b conjugate vaccine
• Haemophilus influenzae type b (Hib) polysaccharide vaccine
• Haemophilus influenzae type b vaccine and whole cell DTP vaccine

Phase 4 trials (4)

• haemophilus influenzae type b-neisseria meningitidis serogroups c and y-tetanus-toxoid conjugate vaccine
• quinvaxem
• trianrix
• acellular pertussis vaccine (including diptheria and tetanus toxoids)

Phase 3 trials (5)

• diphtheria-tetanus-whole cell pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine
• pneumococcal 13-valent conjugate vaccine
• measles, mumps, rubella, varicella vaccine
• bivalent oral polio vaccine (bopv), type 1 and type 3
• diphtheria toxoid

Phase 2 trials (1)

• Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine

Phase 1 trials (4)

• meningococcal (groups A, C, Y, W) CRM197 conjugate vaccine
• meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
• sodium chloride
• haemophilus influenzae type a (hia) glycoconjugate vaccine

Other trials (2)

• glyco-conjugate neisseria meningitidis serogroup c vaccine
• Inactivated polio virus - Enhanced

Organization Involved with Phase 4 Indications (6)

• Crucell
• Sanofi
• Sanofi-Aventis
• Novartis
• GlaxoSmithKline
• LG

Organization Involved with Phase 3 Indications (6)

• Merck
• Beijing Minhai Biotechnology Co., Ltd
• Institut Pasteur
• Government of China
• Chengdu Olymvax Biopharmaceuticals Inc.
• Royal Biological Co., LTD

Organization Involved with Phase 1 Indications (1)

• Korea University